Q/C Technologies, Inc. Earnings Per Share (Basic)
Q/C Technologies, Inc. (QCLS) reported Earnings Per Share (Basic) of -$0.79 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-12
- Q/C Technologies, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.79.
- Q/C Technologies, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.19.
- Q/C Technologies, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$1.26.
- Q/C Technologies, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$2.50.
- Q/C Technologies, Inc. earnings per share, basic for fiscal 2025 was -$8.66.
- Q/C Technologies, Inc. earnings per share, basic for fiscal 2024 was -$1080.87.
- Q/C Technologies, Inc. earnings per share, basic for fiscal 2023 was -$5.33.
- Q/C Technologies, Inc. earnings per share, basic for fiscal 2022 was -$11.74.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.79 10-Q · filed 2026-08-12 | -$0.99 10-Q · filed 2026-08-12 | -$2.04 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$3.19 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2026-03-31 | -$0.19 10-Q · filed 2026-05-15 | -$1.22 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$2.40 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$3.94 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2025-12-31 | -$1.26 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$3.07 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$5.80 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$8.66 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | -$2.50 10-Q · filed 2025-11-19 | -$8.44 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$14.77 10-Q · filed 2025-11-19 | -$6.69 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2025-06-30 | -$51.10 10-Q · filed 2026-08-12 | -$0.18 10-Q · filed 2025-08-19 | -$187.46 10-Q · filed 2026-08-12 | -$0.45 10-Q · filed 2025-08-19 | -$4.33 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$7.71 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||
| 2025-03-31 | -$0.36 10-Q · filed 2026-05-15 | -$1.89 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$4.30 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$9.43 derived: net income ÷ weighted average shares · filed 2026-05-15 | ||||
| 2024-12-31 | -$106.24 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$213.74 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$20.80 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$1080.87 10-K · filed 2026-04-15 | -$11.15 10-K · filed 2025-04-11 | |||
| 2024-09-30 | -$107.62 10-Q · filed 2025-11-19 | -$1.11 10-Q · filed 2024-11-14 | -$11.32 derived: net income ÷ weighted average shares · filed 2025-11-19 | -$1015.18 10-Q · filed 2025-11-19 | -$10.49 10-Q · filed 2024-11-14 | -$18.53 derived: net income ÷ weighted average shares · filed 2025-11-19 | ||
| 2024-06-30 | -$4.54 10-Q · filed 2025-08-19 | -$9.58 10-Q · filed 2025-08-19 | -$12.66 derived: net income ÷ weighted average shares · filed 2025-08-19 | -$12.00 derived: net income ÷ weighted average shares · filed 2025-08-19 | ||||
| 2024-03-31 | -$5.14 10-Q · filed 2025-05-15 | -$8.06 derived: net income ÷ weighted average shares · filed 2025-05-15 | -$7.09 derived: net income ÷ weighted average shares · filed 2025-05-15 | -$10.15 derived: net income ÷ weighted average shares · filed 2025-05-15 | ||||
| 2023-12-31 | -$2.72 derived: net income ÷ weighted average shares · filed 2025-04-11 | -$1.19 derived: net income ÷ weighted average shares · filed 2025-04-11 | -$4.11 derived: net income ÷ weighted average shares · filed 2025-04-11 | -$5.33 10-K · filed 2025-04-11 | ||||
| 2023-09-30 | $1.84 10-Q · filed 2024-11-14 | $0.06 10-Q · filed 2023-11-14 | -$1.11 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$2.28 10-Q · filed 2024-11-14 | -$0.08 10-Q · filed 2023-11-14 | $0.27 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||
| 2023-06-30 | -$3.22 10-Q · filed 2024-08-19 | -$0.11 10-Q · filed 2023-08-14 | -$4.43 10-Q · filed 2024-08-19 | -$0.16 10-Q · filed 2023-08-14 | $0.28 derived: net income ÷ weighted average shares · filed 2024-08-19 | $0.80 derived: net income ÷ weighted average shares · filed 2024-08-19 | ||
| 2023-03-31 | -$1.20 10-Q · filed 2024-05-15 | -$0.04 10-Q · filed 2023-05-15 | $0.10 derived: net income ÷ weighted average shares · filed 2024-05-15 | $0.39 derived: net income ÷ weighted average shares · filed 2024-05-15 | $1.62 derived: net income ÷ weighted average shares · filed 2024-05-15 | |||
| 2022-12-31 | $0.03 derived: net income ÷ weighted average shares · filed 2024-04-01 | $0.21 derived: net income ÷ weighted average shares · filed 2024-04-01 | $1.01 derived: net income ÷ weighted average shares · filed 2024-04-01 | -$11.74 10-K · filed 2024-04-01 | -$0.39 10-K · filed 2023-03-31 | |||
| 2022-09-30 | -$0.09 10-Q · filed 2023-11-14 | -$0.19 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$0.30 10-Q · filed 2023-11-14 | |||||
| 2022-06-30 | -$0.09 10-Q · filed 2023-08-14 | -$0.20 10-Q · filed 2023-08-14 | ||||||
| 2022-03-31 | -$0.11 10-Q · filed 2023-05-15 | |||||||
| 2021-12-31 | -$0.85 10-K · filed 2023-03-31 | |||||||
| 2021-09-30 | -$0.15 10-Q · filed 2022-11-10 | -$0.78 10-Q · filed 2022-11-10 | ||||||
| 2019-09-30 | $1.54 derived: net income ÷ weighted average shares · filed 2020-11-16 | $4.71 derived: net income ÷ weighted average shares · filed 2020-11-16 | ||||||
| 2017-09-30 | -$0.13 10-Q/A · filed 2018-07-13 | -$0.40 10-Q/A · filed 2018-07-13 | -$0.39 10-Q · filed 2017-11-14 | |||||
| 2016-09-30 | $0.06 10-Q/A · filed 2018-07-13 | -$0.41 10-Q/A · filed 2018-07-13 | ||||||
| 2015-09-30 | -$0.45 10-Q · filed 2016-11-14 | -$1.12 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |